Susquehanna International Group’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-35,583
Closed -$193K 13872
2025
Q2
$193K Buy
35,583
+7,395
+26% +$36.9K ﹤0.01% 11245
2025
Q1
$97.8K Buy
28,188
+11,365
+68% +$55.1K ﹤0.01% 11555
2024
Q4
$173K Buy
+16,823
New +$210K ﹤0.01% 10885
2024
Q2
Sell
-30,646
Closed -$289K 13226
2024
Q1
$289K Buy
+30,646
New +$298K ﹤0.01% 9780

Other funds holding THRD

Susquehanna International Group's THRD Position: Q3 2025 in Review

Susquehanna International Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 35,583 shares — an estimated $193K sold.

Susquehanna International Group first reported a position in THRD in Q1 2024 and held it in 4 quarters. The position peaked at $289K in Q1 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Susquehanna International Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 35,583 Third Harmonic Bio shares in Q3 2025, an estimated $193K.
  • Susquehanna International Group first reported a position in Third Harmonic Bio in Q1 2024 and held it in 4 quarters.
  • Susquehanna International Group's Third Harmonic Bio position peaked at $289K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.